Submitted to New England American Urological Association Conference (September 29-October 1, 2022):
Risky Business: The Use of Unregulated Phosphodiesterase Inhibitors in Healthcare Supplements
Distressed communities with high risk stone formers may benefit more from multidisciplinary kidney stone clinic model
Integration of Telehealth at Multidisciplinary Stone Clinic Increases Patient Adherence to Kidney Stone Prevention Visits
A Geographic Analysis of the Endourologic Management of Stones Demonstrates a Variation between Northeastern States
Age of Urologist Predicts Treatment Preference for the Management of Stone Disease
Temporal Trends of Diagnostic Prostate MRI Results
Upcoming Presentations
To be presented at the American Urologic Association Conference (May 13-16, 2022):
Artificial Intelligence in Robotic-Assisted Laparoscopic Prostatectomy: Developing Predictive Models for Positive Surgical Margins
Identifying Bladder Urothelial Carcinomas Using Fluorescent Signal Intensity of pH Low Inserting Peptides
Erectile Function 5 years Following Successful Penis Transplantation
Comparison of Guidance UTI and standard urine culture for rates of sepsis, hospitalization and other adverse outcomes in complicated urinary tract infections
Prostacyclin (Treprostinil) Therapy Improves Renal Hemodynamics During Rat Renal Ischemia-Reperfusion Injury